MMP2, matrix metallopeptidase 2, 4313

N. diseases: 1021; N. variants: 43
Disease: Fetal Growth Retardation ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation 		0.320 Biomarker phenotype BEFREE AF-PROK1 and AF-MMP-2 were not significantly associated with adverse pregnancy outcomes (preeclampsia, intrauterine growth retardation, spontaneous preterm birth, gestational diabetes, gestational hypertension). 29405963 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation 		0.320 Biomarker phenotype CTD_human Placental Stem Villus Arterial Remodeling Associated with Reduced Hydrogen Sulfide Synthesis Contributes to Human Fetal Growth Restriction. 28157488 2017
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation 		0.320 GeneticVariation phenotype BEFREE We conclude that fetal MMP2 -1306 single nucleotide polymorphism (SNP) is associated with an increased risk for IUGR, but not MMP9 -1562 SNP nor MMP9 microsatellite. 17367869 2007
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation 		0.320 GeneticVariation phenotype LHGDN We conclude that fetal MMP2 -1306 single nucleotide polymorphism (SNP) is associated with an increased risk for IUGR, but not MMP9 -1562 SNP nor MMP9 microsatellite. 17367869 2007